Developmental Regulation and Function of AMPA Receptor Subunits in Chicken Lumbar Motoneurons Xianglian Ni University of Vermont
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Regulation of Extracellular Arginine Levels in the Hippocampus in Vivo
Regulation of Extracellular Arginine Levels in the Hippocampus In Vivo by Joanne Watts B.Sc. (Hons) r Thesis submitted for the degree of Doctor of Philosophy in the Faculty of Science, University of London The School of Pharmacy University of London ProQuest Number: 10105113 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10105113 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract Nitric oxide (NO) has emerged as an ubiquitous signaling molecule in the central nervous system (CNS). NO is synthesised from molecular oxygen and the amino acid L-arginine (L- ARG) by the enzyme NO synthase (NOS), and the availability of L-ARG has been implicated as the limiting factor for NOS activity. Previous studies have indicated that L- ARG is localised in astrocytes in vitro and that the in vitro activation of non-N-methyl-D- aspartate (NMDA) receptors, as well as the presence of peroxynitrite (ONOO ), led to the release of L-ARG. Microdialysis was therefore used in this study to investigate whether this held true in vivo. -
Electrochemical and Quantum Chemical Studies on Corrosion Inhibition Performance Of
Materials Research. 2020; 23(2): e20180610 DOI: https://doi.org/10.1590/1980-5373-MR-2018-0610 Electrochemical and Quantum Chemical Studies on Corrosion Inhibition Performance of 2,2’-(2-Hydroxyethylimino)bis[N-(alphaalpha-dimethylphenethyl)-N-methylacetamide] on Mild Steel Corrosion in 1M HCl Solution Iman Danaeea* , S. RameshKumarb, M. RashvandAveic, M. Vijayand aPetroleum University of Technology, Abadan Faculty of Petroleum Engineering, Abadan, Iran bSri Vasavi College, Department of Chemistry, Erode, Tamilnadu-638 316, India. cK. N. Toosi University of Technology, Department of chemistry, Tehran, Iran dCentral Electrochemical Research Institute, Centre for Conducting Polymers, Electrochemical Materials Science Division, Karikudi, 630006, India Received: September 7, 2018; Revised: January 13, 2020; Accepted: March 16, 2020 The inhibitory effect of Oxethazaine drug, 2,2’-(2-Hydroxyethylimino)bis[N-(alphaalpha- dimethylphenethyl)-N-methylacetamide] on corrosion of mild steel in 1M HCl solution was studied by weight loss measurements, electrochemical impedance spectroscopy and potentiodynamic polarization methods. The results of gravimetric and electrochemical methods demonstrated that the inhibition efficiency increased with an increase in inhibitor concentration in 1M HCl solution. The results from electrochemical impedance spectroscopy proved that the inhibition action of this drug was due to adsorption on the metal surface. Potentiodynamic polarization studies revealed that the molecule was a mixed type inhibitor. The adsorption of the molecule on the metal surface was found to obey Langmuir Adsorption isotherm. Potential of zero charge at the metal-solution interface was measured to provide the inhibition mechanism. The temperature dependence of the corrosion rate was also studied in the temperature range from 30 to 50 °C. Quantum chemical calculations were applied to correlate electronic structure parameters of the drug with its inhibition performance. -
Durham E-Theses
Durham E-Theses Molecular pharmacology of a Novel NR2B-selective NMDA Receptor Antagonist Bradford, Andrea Marie How to cite: Bradford, Andrea Marie (2006) Molecular pharmacology of a Novel NR2B-selective NMDA Receptor Antagonist, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/2736/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 Molecular Pharmacology of a Novel NR2B-รelective NMDA Receptor Antagonist PhD Thesis The copyright of this thesis rests with the author or ¿he university to which it was submitted. No quotation from it, or ๒fonnation derived from it may be published without the prior written consent of the author or university, and any information derived from it should be acknowledged. Andrea Marie Bradford School of Biological & Вю^ Sciences University of Durham Supervisor: Dr Paul Chazot October 2006 7 JUM 200? Abstract The NMDA receptor is a heteromeric ligand-gated ion channel in the central nervous system (CNS). -
Glutamate Receptor Antagonism: Neurotoxicity, Anti-Akinetic Effects, and Psychosis
J Neural Transm (1991) [Suppl] 34: 203-210 © by Springer-Verlag 1991 Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis P. Riederer1, K. W. Lange1, J. Kornhuber1, and K. Jellinger2 'Clinical Neurochemistry, Department of Psychiatry, University of Wiirzburg, Federal Republic of Germany 2Ludwig Boltzmann Institute of Clinical Neurobiology, Lainz Hospital, Vienna, Austria Summary. There is evidence to suggest that glutamate and other excitatory amino acids play an important role in the regulation of neuronal excitation. Glutamate receptor stimulation leads to a non-physiological increase of intra• cellular free Ca2+. Disturbed Ca2+ homeostasis and subsequent radical formation may be decisive factors in the pathogenesis of neurodegenerative diseases. Decreased glutamatergic activity appears to contribute to paranoid hallucinatory psychosis in schizophrenia and pharmacotoxic psychosis in Parkinson's disease. It has been suggested that a loss of glutamatergic function causes dopaminergic over-activity. Imbalances of glutamatergic and dopaminer• gic systems in different brain regions may result in anti-akinetic effects or the occurrence of psychosis. The simplified hypothesis of a glutamatergic- dopaminergic (im)-balancc may lead to a better understanding of motor behaviour and psychosis. Introduction It is only recently that excitatory amino acid receptors have been dis• covered. Through the use of selective agonists and antagonists it has become evident that these receptors consist of different subtypes (for review see Watkins et al., 1990). At present the most useful classification provides the following excitatory amino acid receptor subtypes: N-methyl-D-aspartate (NMDA) receptors, kainate receptors, quisqualate receptors or a-amino-3- hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors, metabotropic receptors and L-aminophosphonobutyrate (L-AP4) receptors. -
Functional Impact of Interacting Protein on Kainate Receptors: Necab1 and Neto Proteins
Instituto de Neurociencias de Alicante Universidad Miguel Hernandez Thesis manuscript for: PhD in Neuroscience Functional impact of interacting protein on kainate receptors: NeCaB1 and NeTo proteins. Jon Palacios Filardo Supervised by: Prof. Juan Lerma Alicante, 2014 Agradecimientos/Acknowledgments Agradecimientos/Acknowledgments Ahora que me encuentro escribiendo los agradecimientos, me doy cuenta que esta es posiblemente la única sección de la tesis que no será corregida. De manera que los escribiré tal como soy, tal vez un poco caótico. En primer lugar debo agradecer al profesor Juan Lerma, por la oportunidad que me brindó al permitirme realizar la tesis en su laboratorio. Más que un jefe ha sido un mentor en todos estos años, 6 exactamente, en los que a menudo al verme decía: “Jonny cogió su fusil”, y al final me entero que es el título de una película de cine… Pero aparte de un montón de anécdotas graciosas, lo que guardaré en la memoria es la figura de un mentor, que de ciencia todo lo sabía y le encantaba compartirlo. Sin duda uno no puede escribir un libro así (la tesis) sin un montón de gente alrededor que te enseña y ayuda. Como ya he dicho han sido 6 años conviviendo con unos maravillosos compañeros, desde julio de 2008 hasta presumiblemente 31 de junio de 2014. De cada uno de ellos he aprendido mucho; técnicamente toda la electrofisiología se la debo a Ana, con una paciencia infinita o casi infinita. La biología molecular me la enseñó Isa. La proteómica la aprendí del trío Esther-Ricado-Izabella. Joana y Ricardo me solventaron mis primeras dudas en el mundo de los kainatos. -
Octahydroquinoxalin-2 (1H)-One-Based Aminophosphonic
materials Article Octahydroquinoxalin-2(1H)-One-Based Aminophosphonic Acids and Their Derivatives—Biological Activity towards Cancer Cells Jakub Iwanejko 1 , El˙zbietaWojaczy ´nska 1,* , Eliza Turlej 2 , Magdalena Maciejewska 2 and Joanna Wietrzyk 2 1 Faculty of Chemistry, Wrocław University of Science and Technology, Wybrze˙zeWyspia´nskiego 27, 50-370 Wrocław, Poland; [email protected] 2 Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, Poland; [email protected] (E.T.); [email protected] (M.M.); [email protected] (J.W.) * Correspondence: [email protected]; Tel.: +48-71-320-2410 Received: 19 March 2020; Accepted: 19 May 2020; Published: 22 May 2020 Abstract: In the search for new antitumor agents, aminophosphonic acids and their derivatives based on octahydroquinoxalin-2(1H)-one scaffold were obtained and their cytotoxic properties and a mechanism of action were evaluated. Phosphonic acid and phosphonate moieties increased the antiproliferative activity in comparison to phenolic Mannich bases previously reported. Most of the obtained compounds revealed a strong antiproliferative effect against leukemia cell line (MV-4-11) with simultaneous low cytotoxicity against normal cell line (mouse fibroblasts-BALB/3T3). The most active compound was diphenyl-[(1R,6R)-3-oxo-2,5-diazabicyclo[4.4.0]dec-4-yl]phosphonate. Preliminary evaluation of the mechanism of action showed the proapoptotic effect associated with caspase 3/7 induction. Keywords: aminophosphonate; imine; antiproliferative activity; cell cycle; mitochondrial membrane potential 1. Introduction At present, our attention is focused on the COVID-19 pandemic and there is a tendency to neglect the civilization diseases which however remain the main reason for mortality worldwide. -
Improving Thermodynamic Consistency Among Vapor Pressure, Heat of Vaporization, and Liquid and Ideal Gas Heat Capacities Joseph Wallace Hogge Brigham Young University
Brigham Young University BYU ScholarsArchive All Theses and Dissertations 2017-12-01 Improving Thermodynamic Consistency Among Vapor Pressure, Heat of Vaporization, and Liquid and Ideal Gas Heat Capacities Joseph Wallace Hogge Brigham Young University Follow this and additional works at: https://scholarsarchive.byu.edu/etd Part of the Chemical Engineering Commons BYU ScholarsArchive Citation Hogge, Joseph Wallace, "Improving Thermodynamic Consistency Among Vapor Pressure, Heat of Vaporization, and Liquid and Ideal Gas Heat Capacities" (2017). All Theses and Dissertations. 6634. https://scholarsarchive.byu.edu/etd/6634 This Dissertation is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion in All Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please contact [email protected], [email protected]. Improving Thermodynamic Consistency Among Vapor Pressure, Heat of Vaporization, and Liquid and Ideal Gas Heat Capacities Joseph Wallace Hogge A dissertation submitted to the faculty of Brigham Young University In partial fulfillment of the requirements for the degree of Doctor of Philosophy W. Vincent Wilding, Chair Thomas A. Knotts Dean Wheeler Thomas H. Fletcher John D. Hedengren Department of Chemical Engineering Brigham Young University Copyright © 2017 Joseph Wallace Hogge All Rights Reserved ABSTRACT Improving Thermodynamic Consistency Among Vapor Pressure, Heat of Vaporization, and Liquid and Ideal Gas Heat Capacity Joseph Wallace Hogge Department of Chemical Engineering, BYU Doctor of Philosophy Vapor pressure ( ), heat of vaporization ( ), liquid heat capacity ( ), and ideal gas heat capacity ( ) are important properties for process design and optimization. This work vap Δvap focuses on improving the thermodynamic consistency and accuracy of the aforementioned properties since these can drastically affect the reliability, safety, and profitability of chemical processes. -
|||||||III US005514680A United States Patent (19) 11 Patent Number: 5,514,680 Weber Et Al
|||||||III US005514680A United States Patent (19) 11 Patent Number: 5,514,680 Weber et al. (45) Date of Patent: May 7, 1996 54 GLYCINE RECEPTOR ANTAGONISTS AND 0377112 7/1990 European Pat. Off.. THE USE THEREOF 0511152 10/1992 European Pat. Off.. 572852 12/1993 European Pat. Off.. 2451049 4/1976 Germany. (75) Inventors: Eckard Weber, Laguna Beach, Calif.; 2446543 4/1976 Germany. John F. W. Keana, Eugene, Oreg. 2847285 5/1980 Germany. 72674 11/1974 Poland. 73) Assignees: State of Oregon, acting by and WO91/13878 9/1991 WIPO. through The Oregon State Board of WO92/07847 11/1991 WIPO. Higher Education, acting for and on WO92/O2487 2/1992 WIPO. behalf of The Oregon Health Sciences WO92/11012 7/1992 WIPO. University and The University of WO92/11245 7/1992 WIPO. Oregon, Eugene, Oreg.; The Regents WO92/14740 9/1992 WIPO : of the University of California, WO92/15565 9/1992 WIPO. Oakland, Calif. 94.07500 4/1994 WIPO. OTHER PUBLICATIONS (21) Appl. No.: 148,259. Allison et al., Polyfluoroheterocyclic Compounds, Part XX. 22 Filed: Nov. 5, 1993 Preparation and Nucleophilic Substitution of Hexafluoro quinoxaline, J. Fluorine Chem. 1:59-667 (1971). Related U.S. Application Data Burton et al., Halogeno-o-phenylenediamines and Derived Heterocycles. Part I. Reductive Fission of Benzotriazoles to 63 Continuation-in-part of PCT/US93/05859, Jun. 17, 1993, o-Phenylenediamines, J. Chem. Soc. (C) 10:1268-1273 which is a continuation-in-part of Ser. No. 69,274, May 28, (1968). 1993, abandoned, which is a continuation-in-part of Ser. No. Lutfy et al., Blockade of Morphine Tolerance by 995,167, Dec. -
Synthesis and Characterization of Thermoplastic
SYNTHESIS AND CHARACTERIZATION OF THERMOPLASTIC POLYPHENOXYQUINOXALINES A Dissertation Presented to The Graduate Faculty of the University of Akron In Partial Fulfillment of the Requirement for the Degree Doctor of Philosophy Haci Bayram Erdem May, 2008 © 2008 HACI BAYRAM ERDEM ALL RIGHTS RESERVED SYNTHESIS AND CHARACTERIZATION OF THERMOPLASTIC POLYPHENOXYQUINOXALINES Haci Bayram Erdem Dissertation Approved: Accepted: ______________________________ _____________________________ Advisor Department Chair Frank W. Harris Mark D. Foster ______________________________ _____________________________ Committee Member Dean of the College Stephen Z. D. Cheng Stephen Z. D. Cheng ______________________________ _____________________________ Committee Member Dean of the Graduate School Judit Puskas George R. Newkome ______________________________ _____________________________ Committee Member Date Roderic P. Quirk ______________________________ Committee Member David A. Modarelli ii ABSTRACT This research was divided into two main parts. In the first part, a new facile route to relatively inexpensive thermoplastic polyphenoxyquinoxalines was developed. The synthetic route involves the aromatic nucleophilic substitution reaction of bisphenols with 2,3-dichloroquinoxaline. The dichloro monomer was prepared in two steps. In the first step, oxalic acid was condensed with o-phenylenediamine to give 2,3- dihydroxyquinoxaline. In the second step, 2,3-dihydroxyquinoxaline was treated with thionyl chloride to give 2,3-dichloroquinoxaline. This monomer was successfully polymerized with bisphenol-A, bisphenol-S, hexafluorobisphenol-A and 9,9-bis(4- hydroxyphenyl)fluorenone. Hydroquinone and biphenol, however, can not be polymerized to high molecular weight polymers because of the premature precipitation of crystalline oligomers. The glass transition temperatures of the high molecular weight polymers prepared from a series of bisphenols range from 191 °C to 279 °C, and their thermal decomposition temperatures are around 500 °C. -
Synthesis and Cytotoxic Evaluation of Some Novel Quinoxalinedione Diarylamide Sorafenib Analogues
Research in Pharmaceutical Sciences, April 2018; 13(2): 168-176 School of Pharmacy & Pharmaceutical Sciences Received:September 2017 Isfahan University of Medical Sciences Accepted: January 2018 Original Article Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues Mojtaba Khandan, Sedighe Sadeghian-Rizi, Ghadamali Khodarahmi, and Farshid Hassanzadeh* Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, I.R. Iran Abstract A series of novel sorafenib analogues containing a quinoxalinedione ring and amide linker were synthesized. A total of 9 novel compounds in 6 synthetic steps were synthesized. Briefly, the amino group of p-aminophenol was first protected which then followed by O-arylation with 5-chloro-2-nitroaniline to provide compound d. Reduction of the nitro group of compound d and cyclization of the diamine group of compound e with oxalic acid afforded compound f which on deacetylation yeilded compound g. Then compound g was reacted with different acyl halides to afford the target compounds 1h-1p. Chemical structures of synthesized compounds were confirmed by 1H NMR and FT-IR analysis. All compounds were evaluated at 1, 10, 50 and 100 μM concentrations for their cytotoxicity against HeLa and MCF-7 cancer cell lines. Some of the compounds showed good cytotoxic activity, especially compounds 1i and 1k-1n with the IC50 values of 19, 16, 22, 18, and 16 µM against MCF-7 cell line and 20, 18, 25, 20, and 18 µM against HeLa cell line, respectively. Keywords: Cytotoxicity; Sorafenib; Quinoxalinedione; Amide INTRODUCTION cancer types such as metastatic colorectal, brain, leukemia, breast, glioblastoma, Cancer, one of the most serious illnesses, advanced gastric, cervical, thyroid, non-small considered the second leading cause of death cell lung cancer, prostate, bladder and worldwide after cardiovascular diseases. -
Imidazole-Substituted Quinoxalinedione Derivatives
s\ — Illl INI II II III lllll I Mil II I II OJII Eur°Pean Patent Office <*S Office europeen des brevets (11) EP 0 919 554 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC (43) Date of publication: (51) Int. CI.6: C07D 403/04, C07D 403/12, 02.06.1999 Bulletin 1999/22 A61K 31/495 (21) Application number: 97925284.8 v ' ^ (86)/0~x International application number:u PCT/JP97/01905 (22) Date of filing: 05.06.1997 (87) International publication number: WO 97/46555 (1 1 .1 2.1 997 Gazette 1 997/53) (84) Designated Contracting States: • OHMORI, Junya AT BE CH DE DK ES Fl FR GB GR IE IT LI LU NL Tsukuba-shi, Ibaraki 305 (JP) PTSE • SHISHIKURA, Jun-ichi Tsukuba-shi, Ibaraki 305 (JP) (30) Priority: 06.06.1996 JP 144282/96 • OKADA, Masamichi Tsukuba-shi, Ibaraki 305 (JP) (71) Applicant: . SASAMATA Masao YAMANOUCHI PHARMACEUTICAL CO., LTD. Tsukuba-gu'n, Ibaraki 300-24 (JP) Tokyo 103 (JP) (74) Representative: (72) Inventors: Geering, Keith Edwin • SAKAMOTO, Shuichi REDDIE & GROSE Ushiku-shi, Ibaraki 300-1 2 (JP) ! 6 Theobalds Road London WC1X8PL(GB) (54) IMIDAZOLE-SUBSTITUTED QUINOXALINEDIONE DERIVATIVES (57) Imidazole-substituted quinoxalinedione deriva- R1 is a triazolyl group, tives the formula represented by following general (I) or R2: a hydrogen atom, a nitro group, a halogeno- salts thereof and pharmaceutically acceptable pharma- lower alkyl group, a cyano group, an amino group, a ceutical useful compositions as glutamate receptor mono- or di-lower alkylamino group or a halogen antagonists and the like, which comprise said com- atom, salts thereof and pounds or pharmaceutically accepta- Pi3 and Pi4: may be the same or different from each ble carriers. -
Oxford Handbooks Online (
AMPA and Kainate Receptors AMPA and Kainate Receptors G. Brent Dawe, Patricia M. G. E. Brown, and Derek Bowie The Oxford Handbook of Neuronal Ion Channels Edited by Arin Bhattacharjee Subject: Neuroscience, Molecular and Cellular Systems Online Publication Date: Oct 2020 DOI: 10.1093/oxfordhb/9780190669164.013.8 Abstract and Keywords α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate-type gluta mate receptors (AMPARs and KARs) are dynamic ion channel proteins that govern neu ronal excitation and signal transduction in the mammalian brain. The four AMPAR and five KAR subunits can heteromerize with other subfamily members to create several com binations of tetrameric channels with unique physiological and pharmacological proper ties. While both receptor classes are noted for their rapid, millisecond-scale channel gat ing in response to agonist binding, the intricate structural rearrangements underlying their function have only recently been elucidated. This chapter begins with a review of AMPAR and KAR nomenclature, topology, and rules of assembly. Subsequently, receptor gating properties are outlined for both single-channel and synaptic contexts. The struc tural biology of AMPAR and KAR proteins is also discussed at length, with particular fo cus on the ligand-binding domain, where allosteric regulation and alternative splicing work together to dictate gating behavior. Toward the end of the chapter there is an overview of several classes of auxiliary subunits, notably transmembrane AMPAR regula tory proteins and Neto proteins, which enhance native AMPAR and KAR expression and channel gating, respectively. Whether bringing an ion channel novice up to speed with glutamate receptor theory and terminology or providing a refresher for more seasoned biophysicists, there is much to appreciate in this summation of work from the glutamate receptor field.